Use of a Silicon Stoma Stent as an Interim Step in High-Risk Tracheostomy Decannulation

Objective To describe use of a stoma stent to facilitate high-risk decannulation. Methods Retrospective chart review of 14 consecutive patients who received a stent from March 2013 to December 2016 at a quaternary health care service. Primary outcome measures were decannulation outcome and adverse e...

Full description

Bibliographic Details
Main Authors: Jacqueline Ross, Kristy McMurray, Tanis Cameron MA, Celia Lanteri PhD, FRACP, BMBS
Format: Article
Language:English
Published: Wiley 2019-03-01
Series:OTO Open
Online Access:https://doi.org/10.1177/2473974X19836432
_version_ 1797669326669479936
author Jacqueline Ross
Kristy McMurray
Tanis Cameron MA
Celia Lanteri PhD, FRACP, BMBS
author_facet Jacqueline Ross
Kristy McMurray
Tanis Cameron MA
Celia Lanteri PhD, FRACP, BMBS
author_sort Jacqueline Ross
collection DOAJ
description Objective To describe use of a stoma stent to facilitate high-risk decannulation. Methods Retrospective chart review of 14 consecutive patients who received a stent from March 2013 to December 2016 at a quaternary health care service. Primary outcome measures were decannulation outcome and adverse events. Results Decannulation outcome: 12 of 14 patients had their tracheostomy tube (TT) removal facilitated by stent use. Patients had the stent for a median of 6 days (interquartile range, 49). Reasons for use included medical instability, risk of sputum retention, uncertain airway patency, and the need for ongoing airway access. All patients survived to discharge. One patient residing in the community has retained a stoma stent. Adverse events: One patient removed the stent on the day of insertion, necessitating reinsertion of the TT. Granulation tissue at the stoma site was seen in 2 patients. Discussion A tracheostoma will normally close within 48 hours following decannulation, which is problematic if TT reinsertion is required. By using the stent, reversal of decannulation becomes a simple ward-based procedure. In comparison to a TT, which is secured with ties, the stoma stent proved unsuitable for use in an agitated patient. Implications for Practice Decreasing total cannulation time is of benefit as patients with tracheostomy are subject to high rates of complications and adverse events. A stoma stent poses little risk and a low morbidity burden to the patient in comparison to alternative management.
first_indexed 2024-03-11T20:42:37Z
format Article
id doaj.art-a5b37d06774c455c87749f16daf3c94c
institution Directory Open Access Journal
issn 2473-974X
language English
last_indexed 2024-03-11T20:42:37Z
publishDate 2019-03-01
publisher Wiley
record_format Article
series OTO Open
spelling doaj.art-a5b37d06774c455c87749f16daf3c94c2023-10-02T00:57:27ZengWileyOTO Open2473-974X2019-03-01310.1177/2473974X19836432Use of a Silicon Stoma Stent as an Interim Step in High-Risk Tracheostomy DecannulationJacqueline Ross0Kristy McMurray1Tanis Cameron MA2Celia Lanteri PhD, FRACP, BMBS3Victorian Spinal Cord Service, Melbourne, AustraliaAustralian Nursing Federation, Melbourne, AustraliaDepartment of Speech Pathology, Austin Health, Melbourne, AustraliaInstitute of Breathing and Sleep, Austin Health, Melbourne, AustraliaObjective To describe use of a stoma stent to facilitate high-risk decannulation. Methods Retrospective chart review of 14 consecutive patients who received a stent from March 2013 to December 2016 at a quaternary health care service. Primary outcome measures were decannulation outcome and adverse events. Results Decannulation outcome: 12 of 14 patients had their tracheostomy tube (TT) removal facilitated by stent use. Patients had the stent for a median of 6 days (interquartile range, 49). Reasons for use included medical instability, risk of sputum retention, uncertain airway patency, and the need for ongoing airway access. All patients survived to discharge. One patient residing in the community has retained a stoma stent. Adverse events: One patient removed the stent on the day of insertion, necessitating reinsertion of the TT. Granulation tissue at the stoma site was seen in 2 patients. Discussion A tracheostoma will normally close within 48 hours following decannulation, which is problematic if TT reinsertion is required. By using the stent, reversal of decannulation becomes a simple ward-based procedure. In comparison to a TT, which is secured with ties, the stoma stent proved unsuitable for use in an agitated patient. Implications for Practice Decreasing total cannulation time is of benefit as patients with tracheostomy are subject to high rates of complications and adverse events. A stoma stent poses little risk and a low morbidity burden to the patient in comparison to alternative management.https://doi.org/10.1177/2473974X19836432
spellingShingle Jacqueline Ross
Kristy McMurray
Tanis Cameron MA
Celia Lanteri PhD, FRACP, BMBS
Use of a Silicon Stoma Stent as an Interim Step in High-Risk Tracheostomy Decannulation
OTO Open
title Use of a Silicon Stoma Stent as an Interim Step in High-Risk Tracheostomy Decannulation
title_full Use of a Silicon Stoma Stent as an Interim Step in High-Risk Tracheostomy Decannulation
title_fullStr Use of a Silicon Stoma Stent as an Interim Step in High-Risk Tracheostomy Decannulation
title_full_unstemmed Use of a Silicon Stoma Stent as an Interim Step in High-Risk Tracheostomy Decannulation
title_short Use of a Silicon Stoma Stent as an Interim Step in High-Risk Tracheostomy Decannulation
title_sort use of a silicon stoma stent as an interim step in high risk tracheostomy decannulation
url https://doi.org/10.1177/2473974X19836432
work_keys_str_mv AT jacquelineross useofasiliconstomastentasaninterimstepinhighrisktracheostomydecannulation
AT kristymcmurray useofasiliconstomastentasaninterimstepinhighrisktracheostomydecannulation
AT taniscameronma useofasiliconstomastentasaninterimstepinhighrisktracheostomydecannulation
AT celialanteriphdfracpbmbs useofasiliconstomastentasaninterimstepinhighrisktracheostomydecannulation